Shingrix Tied to Higher Risk of Ophthalmic Shingles Recurrence

(MedPage Today) -- The recombinant zoster vaccine (RZV; Shingrix) was associated with a significantly increased risk of recurrence of herpes zoster ophthalmicus (HZO), according to a retrospective cohort study. Within 56 days after the start of...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news